Observational Study
. 2018 Mar;154(4):906-915.e7. doi: 10.1053/j.gastro.2017.11.005. Epub 2017 Nov 14. Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal CancerAffiliations
AffiliationsItem in Clipboard
Observational Study
Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal CancerHelmneh M Sineshaw et al. Gastroenterology. 2018 Mar.
. 2018 Mar;154(4):906-915.e7. doi: 10.1053/j.gastro.2017.11.005. Epub 2017 Nov 14. AffiliationsItem in Clipboard
AbstractBackground & aims: Previous studies reported that black vs white disparities in survival among elderly patients with colorectal cancer (CRC) were because of differences in tumor characteristics (tumor stage, grade, nodal status, and comorbidity) rather than differences in treatment. We sought to determine the contribution of differences in insurance, comorbidities, tumor characteristics, and treatment receipt to disparities in black vs white patients with CRC 18-64 years old.
Methods: We used data from the National Cancer Database, a hospital-based cancer registry database sponsored by the American College of Surgeons and the American Cancer Society, on non-Hispanic black (black) and non-Hispanic white (white) patients, 18-64 years old, diagnosed from 2004 through 2012 with single or first primary invasive stage I-IV CRC. Each black patient was matched, based on demographic, insurance, comorbidity, tumor, and treatment features, with 5 white patients, from partially overlapping subgroups, using propensity score and greedy matching algorithms. We used the Kaplan-Meier method to estimate 5-year survival and Cox proportional hazards models to generate hazard ratios.
Results: The absolute 5-year survival difference between black and white unmatched patients with CRC was 9.2% (57.3% for black patients vs 66.5% for white patients; P < .0001). The absolute difference in survival did not change after patient groups were matched for demographics, but decreased to 4.9% (47% relative decrease [4.3% of 9.2%]) when they were matched for insurance and to 2.3% when they were matched for tumor characteristics (26% relative decrease [2.4% of 9.2%]). Further matching by treatment did not reduce the difference in 5-year survival between black and white patients. In proportional hazards model, insurance and tumor characteristics matching accounted for the 54% and 27% excess risk of death in black patients, respectively.
Conclusions: In an analysis of data from the National Cancer Database, we found that insurance coverage differences accounted for approximately one half of the disparity in survival rate of black vs white patients with CRC, 18-64 years old; tumor characteristics accounted for a quarter of the disparity. Affordable health insurance coverage for all populations could substantially reduce differences in survival times of black vs white patients with CRC.
Keywords: Colon Cancer; Comorbidity; Mortality; Race.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statementConflict of Interest: The authors disclose no conflicts of interest.
FiguresFigure 1
Flow chart of cohort inclusion/exclusion…
Figure 1
Flow chart of cohort inclusion/exclusion criteria for 18–64 years old patients with stage…
Figure 1Flow chart of cohort inclusion/exclusion criteria for 18–64 years old patients with stage I–IV colorectal cancer in the National Cancer Data Base (2004–2012).
Figure 2
Overall 5-year survival curves for…
Figure 2
Overall 5-year survival curves for 18–64 years old NH blacks and five sequentially…
Figure 2Overall 5-year survival curves for 18–64 years old NH blacks and five sequentially matched 18–64 years old NH whites with colorectal cancer.
Figure 3
Hazard ratios of all-cause 5-year…
Figure 3
Hazard ratios of all-cause 5-year mortality risk for 18–64 years old NH blacks…
Figure 3Hazard ratios of all-cause 5-year mortality risk for 18–64 years old NH blacks versus sequentially matched 18–64 years old NH whites for patients diagnosed with colorectal cancer Abbreviation: NH, non-Hispanic
Similar articlesLai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H. Lai Y, et al. Gastroenterology. 2016 May;150(5):1135-1146. doi: 10.1053/j.gastro.2016.01.030. Epub 2016 Feb 2. Gastroenterology. 2016. PMID: 26836586 Free PMC article.
Robbins AS, Pavluck AL, Fedewa SA, Chen AY, Ward EM. Robbins AS, et al. J Clin Oncol. 2009 Aug 1;27(22):3627-33. doi: 10.1200/JCO.2008.20.8025. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470927
Jemal A, Robbins AS, Lin CC, Flanders WD, DeSantis CE, Ward EM, Freedman RA. Jemal A, et al. J Clin Oncol. 2018 Jan 1;36(1):14-24. doi: 10.1200/JCO.2017.73.7932. Epub 2017 Oct 16. J Clin Oncol. 2018. PMID: 29035645
Tammana VS, Laiyemo AO. Tammana VS, et al. World J Gastroenterol. 2014 Jan 28;20(4):869-76. doi: 10.3748/wjg.v20.i4.869. World J Gastroenterol. 2014. PMID: 24574761 Free PMC article. Review.
Alexander DD, Waterbor J, Hughes T, Funkhouser E, Grizzle W, Manne U. Alexander DD, et al. Cancer Biomark. 2007;3(6):301-13. doi: 10.3233/cbm-2007-3604. Cancer Biomark. 2007. PMID: 18048968 Free PMC article. Review.
Patel A, Gantz O, Zagadailov P, Merchant AM. Patel A, et al. Updates Surg. 2019 Sep;71(3):523-531. doi: 10.1007/s13304-019-00632-5. Epub 2019 Feb 20. Updates Surg. 2019. PMID: 30788664
Syrnioti G, Eden CM, Johnson JA, Alston C, Syrnioti A, Newman LA. Syrnioti G, et al. Ann Surg Oncol. 2023 Dec;30(13):8094-8104. doi: 10.1245/s10434-023-14200-0. Epub 2023 Sep 18. Ann Surg Oncol. 2023. PMID: 37723358 Review.
Shao Z, Zheng S, Chen C, Lyu J. Shao Z, et al. Int J Gen Med. 2021 Oct 28;14:7317-7327. doi: 10.2147/IJGM.S334071. eCollection 2021. Int J Gen Med. 2021. PMID: 34737626 Free PMC article.
Ko NY, Hong S, Winn RA, Calip GS. Ko NY, et al. JAMA Oncol. 2020 Mar 1;6(3):385-392. doi: 10.1001/jamaoncol.2019.5672. JAMA Oncol. 2020. PMID: 31917398 Free PMC article.
Penny CL, Tanino SM, Mosca PJ. Penny CL, et al. Ann Surg Oncol. 2022 May;29(5):3122-3133. doi: 10.1245/s10434-021-11161-0. Epub 2022 Jan 18. Ann Surg Oncol. 2022. PMID: 35041096
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3